Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares closed down 1.68% on December 31, 2015. The stock’s
Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced the successful completion of its previously announced acquisition of Zuplenz
Singapore is all set to open a stem cell bank, which will allow members of the public to store their own stem cells for the future, officials said.
